Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Robustness Evaluation in Analytical Method Validation – V 2.0

Posted on By

Analytical Method Development: SOP for Robustness Evaluation in Analytical Method Validation – V 2.0

Standard Operating Procedure for Assessing Robustness in Analytical Method Validation


Department Analytical Method Development
SOP No. SOP/AMD/373/2025
Supersedes SOP/AMD/373/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 04/06/2025
Review Date 01/06/2027

1. Purpose

This Standard Operating Procedure (SOP) provides the methodology to evaluate the robustness of analytical methods during development and validation. Robustness testing ensures that minor changes in method parameters do not significantly affect

analytical performance, thereby supporting method reliability under varied laboratory conditions.

2. Scope

This SOP applies to all chromatographic (HPLC, GC), spectrophotometric, potentiometric, and titrimetric analytical methods developed and validated by the Analytical Method Development (AMD) department.

3. Responsibilities

  • Analyst: Conducts experiments to test robustness under deliberate parameter variations.
  • Method Developer: Selects parameters for robustness evaluation and interprets the data.
  • QA Personnel: Reviews robustness results and verifies compliance with acceptance criteria and documentation standards.
See also  Analytical Method Development: SOP for Color Uniformity Analysis in Coated Tablets - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring robust methods are developed and validated, and for approving the robustness evaluation reports included in method validation dossiers.

5. Procedure

5.1 Definition

Robustness is the measure of an analytical method’s capacity to remain unaffected by small, deliberate variations in method parameters, demonstrating its reliability during normal usage.

5.2 Parameters Commonly Evaluated

  1. Column oven temperature (±2°C)
  2. Flow rate (±0.1 mL/min for HPLC)
  3. Mobile phase composition (±2% organic content)
  4. pH of buffer (±0.2 units)
  5. Injection volume (±10%)
  6. Wavelength (±2 nm for UV detection)

5.3 Experimental Setup

  1. Define a robustness protocol as part of the validation plan.
  2. Analyze at least three replicate injections per parameter condition.
  3. Ensure all chromatographic runs are processed using consistent integration settings.
See also  Analytical Method Development: SOP for Preparation and Standardization of Volumetric Solutions - V 2.0

5.4 Acceptance Criteria

  • No significant change in retention time (±2%)
  • No significant change in peak area (±5%)
  • %RSD of replicate injections ≤ 2.0%
  • Resolution between critical peaks should meet system suitability criteria

5.5 Data Recording

  1. Document results in the Robustness Evaluation Log (Annexure-1).
  2. Include chromatograms, overlays, and summary statistics in the validation report.
  3. Highlight any sensitivity to parameters and recommend fixed conditions if necessary.

5.6 Interpretation

  • If significant deviations are observed, adjust method parameters or specify operational controls in the method SOP.
  • Results help determine system suitability limits for future routine analysis.

6. Abbreviations

  • RSD: Relative Standard Deviation
  • Rs: Resolution
  • UV: Ultraviolet
  • GC: Gas Chromatography
  • HPLC: High Performance Liquid Chromatography

7. Documents

  1. Annexure-1: Robustness Evaluation Log
  2. Annexure-2: Validation Protocol Reference Table
  3. Method Validation Summary Report

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • USP General Chapter <1225> Validation of Compendial Procedures
  • 21 CFR Part 211
See also  Analytical Method Development: SOP for Preservative Efficacy in Eye Drops - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Pooja Rawat Ravi Kakkar Dr. Neeta Malhotra
Designation Analyst – AMD QA Officer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Robustness Evaluation Log

Parameter Condition RT Area %RSD Remarks
Flow Rate 0.9 mL/min 6.45 2489 0.92 Acceptable
Flow Rate 1.1 mL/min 6.18 2431 1.03 Acceptable

Annexure-2: Validation Protocol Reference Table

  • Parameter Adjustments: ± as defined in protocol
  • Analyst Initials: PR
  • Date: 01/06/2025

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded criteria and parameter list for broader application Annual SOP review Dr. Neeta Malhotra
15/04/2022 1.0 Initial issue New method validation guideline QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Linearity Evaluation in Analytical Methods – V 2.0
Next Post: Analytical Method Development: SOP for Qualification of HPLC Columns – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version